December 18, 2017

Percepción e interpretación tienen los médicos alergistas de los informes sobre pólenes y hongos ambientales

Estimado Doctor,

Estamos estudiando el uso y la percepción de los informes de pólenes y hongos ambientales en la comunidad. Esto nos permitirá identificar mejoras potenciales para este tipo de informes y aumentar su eficacia en la práctica médica, tanto asistencial cómo académico.

Le solicitamos que responda con su experiencia de acuerdo a los informes de pólenes y hongos las  siguientes preguntas. 


1) evaluar el uso de los informes de pólenes y hongos por los médicos y los pacientes con esta alergia.

2) estimar la utilización de los informes de pólenes los pacientes con alergia. 

3) medición de pólenes en la comunidad médica.

4) la tasa de uso de los informes de pólenes

5) evaluar el vínculo entre las dimensiones previas (percepción y utilización) y los perfiles del paciente (edad, sexo, nivel de SES) y los perfiles del médico (edad, sexo, experiencia, etc.).

Muchas gracias por su tiempo. 

Comité de Aerobiología de la SLaai

Respiratory effect of beta-blockers in people with asthma and cardiovascular disease: population-based nested case control study

Open Access
Open Peer Review
  • Daniel R. MoralesEmail author,
  • Brian J. Lipworth,
  • Peter T. Donnan,
  • Cathy Jackson and
  • Bruce Guthrie

Cardiovascular disease (CVD) is a common comorbidity in people with asthma. However, safety concerns have caused heterogeneity in clinical guideline recommendations over the use of cardioselective beta-blockers in people with asthma and CVD, partly because risk in the general population has been poorly quantified.

December 17, 2017

Physiotherapy breathing retraining for asthma: a randomised controlled trial

December 4, 2017

A pilot study with early adolescents: dealing with diet, tobacco and air pollution using practical experiences and biological markers

Open Access
  • Chiara Marabelli,
  • Elena MunariniEmail authorView ORCID ID profile,
  • Micaela Lina,
  • Roberto Mazza,
  • Roberto Boffi,
  • Cinzia De Marco,
  • Ario Ruprecht,
  • Giorgia Angellotti,
  • Chiara Veronese,
  • Paolo Pozzi,
  • Eleonora Bruno,
  • Giuliana Gargano,
  • Adalberto Cavalleri,
  • Giulia Garrone and
  • Franco Berrino
Multidisciplinary Respiratory Medicine201712:30

Background: Tobacco use and the Western diet are two of the most important and investigated topics in relation to adolescents’ health. In addition, air pollution is a crucial subject for future generations. School is a key social environment that should promote healthy behaviors in children and adolescents. In this field many different programs have been conducted, with mixed results and effectiveness. Research data suggest that comprehensive and multicomponent approaches may have a greater effect on tobacco use and diet, especially when integrated into a community-wide approach.

November 29, 2017

Adverse drug reactions of montelukast in children and adults


  • Principal Investigator: Tjalling W de Vries MD PhD
Montelukast, a selective leukotriene receptor antagonist, is recommended in guidelines for the treatment of asthma in both children and adults. However, its effectiveness is debated, and recent studies have reported several adverse events such as neuropsychiatric disorders and allergic granulomatous angiitis.

November 20, 2017

Novel therapeutic approaches to simultaneously target rhinovirus infection and asthma/COPD pathogenesis

Mirabelli C, Scheers E and Neyts J. Novel therapeutic approaches to simultaneously target rhinovirus infection and asthma/COPD pathogenesis [version 1; referees: 2 approved]F1000Research 2017, 6(F1000 Faculty Rev):1860 (doi: 10.12688/f1000research.11978.1)
Rhinoviruses are exclusive respiratory pathogens and the etiological agents of the common cold. These viruses are increasingly reported to cause exacerbations of asthma and chronic obstructive pulmonary disease (COPD). Here, we review the role of rhinovirus infections in the pathogenesis of asthma and COPD and we discuss the current and potential future treatments. We propose that, in order to prevent exacerbations, the design of novel therapeutics should focus on directly acting antivirals but also include the design of drugs that simultaneously inhibit viral replication and alleviate symptoms of asthma and COPD.

Allergists on Social Media